REFERENCES
- Stehman-Breen C. Osteoporosis and chronic kidney disease. Semin Nephrol. 2004;24:78–81
- Gal-Moscovici A, Sprague SM. Osteoporosis and chronic kidney disease. Semin Dial. 2007;20:423–430.
- Levis S, Altman R. Bone densitometry: Clinical consideration. Arthritis Rheum. 1998;41:577–578.
- Baim S, Binkley N, Bilezikian JP, Official positions of the international society for clinical densitometry end executive summary of the 2007 ISCD position development conference. J Clin Densitom. 2008;11:75–91.
- Adams J, Bishop N. DXA in adults and children. In: Rosen JE, ed. Primer on the Metabolic Bone Disease and Disorders of Mineral Metabolism. Washington, DC: American Society for Bone and Mineral Research; 2008:152–158.
- Elder G. Pathophysiology and recent advances in the management of renal osteodystrophy. J Bone Miner Res. 2002;17:2094–2105.
- KDOQI, National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(3):1–201.
- Martin KJ, Olgaard K, Coburn JW, Diagnosis, assessment and treatment of bone turnover abnormalities in renal osteodystrophy. Am J Kidney Dis. 2004;43:558–565.
- Hruska KA, Mathew S. Chronic kidney disease mineral bone disorder (CKD-MBD). In: Rosen JE, ed. Primer on the Metabolic Bone Disease and Disorders of Mineral Metabolism. Washington, DC: American Society for Bone and Mineral Research; 2008:343–349.
- Cunningham J, Sprague SM, Cannata-Andia J, Osteoporosis in chronic kidney disease. Am J Kidney Dis. 2004;43:566–571.
- Grampp S, Genant HK, Mathur A, Comparison of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination, and diagnostic classification. J Bone Miner Res. 1997;12:697–711.
- Ersoy FF. Osteoporosis in the elderly with chronic kidney disease. Int Urol Nephrol. 2007;39:321–331.
- Pavlović D, Tomić Brzac H. Prevention and treatment of secondary hyperparathyroidism: Still a challenge for the nephrologist? Nephrol Dial Transplant. 2003;18(5):45–46.
- Lindberg JS, Moe MS. Osteoporosis in end-stage renal disease. Semin Nephrol. 1999;19:115–122.
- Kanenko TM, Foley RN, Gilbertson DT, Collins AJ. Clinical epidemiology of long-bone fractures in patients receiving hemodialysis. Clin Orthop Relat Res. 2007;457:188–193.
- Negri AL, Barone R, Quiroga MA, Bone mineral density: Serum markers of bone turnover and their relationships in peritoneal dialysis. Perit Dial Int. 2004;24:163–168.
- Ersoy FF, Passadakis SP, Tam P, Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis. J Bone Miner Metab. 2006;24:79–86.
- Urena P, Bernard-Poenaru O, Ostertag A, Bone mineral density, biochemical markers and skeletal fractures in hemodialysis patients. Nephrol Dial Transplant. 2003;18:2325–2331.
- Leinau L, Perazella MA. Hip fractures in end-stage renal disease patients: Incidence, risk factors and prevention. Semin Dial. 2006;19:75–79.
- Doumouchtsis KK, Kostakis AI, Doumouchtsis SK, Associations between osteoprotegerin and femoral neck BMD in hemodialysis patients. J Bone Miner Metab. 2008;26:66–72.
- Bacchetta J, Boutroy S, Jillrad L, Bone imaging and chronic kidney disease: Will high-resolution peripheral tomography improve bone evaluation and therapeutic management? J Ren Nutr. 2009;19:44–49.